• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adjuvant chemotherapy for high-risk operable breast cancer.

作者信息

Buzdar Aman U

出版信息

J Clin Oncol. 2007 May 1;25(13):1642-4. doi: 10.1200/JCO.2006.09.9796. Epub 2007 Apr 2.

DOI:10.1200/JCO.2006.09.9796
PMID:17404366
Abstract
摘要

相似文献

1
Adjuvant chemotherapy for high-risk operable breast cancer.
J Clin Oncol. 2007 May 1;25(13):1642-4. doi: 10.1200/JCO.2006.09.9796. Epub 2007 Apr 2.
2
[Have therapeutic measures improved the prognosis of operable breast cancer? Adjuvant chemotherapy].[治疗措施是否改善了可手术乳腺癌的预后？辅助化疗]
Verh Dtsch Ges Inn Med. 1985;91:421-8.
3
Induction chemotherapy of breast cancer.乳腺癌的诱导化疗。
Prog Clin Biol Res. 1985;201:105-16.
4
[Future direction of adjuvant chemotherapy for breast cancer following new risk categories of St. Gallen Consensus].[圣加仑共识新风险分类下乳腺癌辅助化疗的未来方向]
Nihon Rinsho. 2007 Jun 28;65 Suppl 6:407-13.
5
Preoperative chemotherapy in the treatment of inflammatory breast cancer.术前化疗在炎性乳腺癌治疗中的应用
Prog Clin Biol Res. 1985;201:95-104.
6
[New approaches in adjuvant chemotherapy of breast cancer].[乳腺癌辅助化疗的新方法]
Gynakol Rundsch. 1988;28(2):123-5.
7
[Neoadjuvant systemic chemotherapy for patients with operable breast cancer].[可手术乳腺癌患者的新辅助全身化疗]
Zhonghua Zhong Liu Za Zhi. 2007 Mar;29(3):161-5.
8
[Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].[化疗中剂量强度的重要性——早期乳腺癌辅助化疗的经验教训]
Rinsho Ketsueki. 2009 Apr;50(4):276-81.
9
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.高风险可手术乳腺癌强化剂量密集与高剂量辅助化疗的比较：西南肿瘤协作组/肿瘤组9623研究
J Clin Oncol. 2007 May 1;25(13):1677-82. doi: 10.1200/JCO.2006.08.9383. Epub 2007 Apr 2.
10
Long-term tamoxifen therapy for breast cancer.乳腺癌的长期他莫昔芬治疗
Important Adv Oncol. 1989:179-92.

引用本文的文献

1
Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor as a support for chemotherapy for gestational trophoblastic neoplasia: a propensity score matching analysis.聚乙二醇化重组人粒细胞集落刺激因子作为妊娠滋养细胞肿瘤化疗支持治疗的疗效和安全性：倾向评分匹配分析
Front Oncol. 2025 Sep 22;15:1590189. doi: 10.3389/fonc.2025.1590189. eCollection 2025.
2
Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.聚乙二醇化重组人粒细胞集落刺激因子 3mg 支持肺癌化疗的疗效和安全性。
Thorac Cancer. 2022 Jan;13(1):117-125. doi: 10.1111/1759-7714.14233. Epub 2021 Nov 17.
3
Efficacy, safety and proper dose analysis of PEGylated granulocyte colony-stimulating factor as support for dose-dense adjuvant chemotherapy in node positive Chinese breast cancer patients.
聚乙二醇化粒细胞集落刺激因子在支持中国淋巴结阳性乳腺癌患者进行剂量密集辅助化疗中的疗效、安全性及合适剂量分析
Oncotarget. 2017 May 24;8(45):80020-80028. doi: 10.18632/oncotarget.18145. eCollection 2017 Oct 3.
4
Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.在接受蒽环类化疗的癌症患者中降低心脏毒性的不同给药方案。
Cochrane Database Syst Rev. 2016 Mar 3;3(3):CD005008. doi: 10.1002/14651858.CD005008.pub4.